The Montreal Cognitive Assessment, or MoCA, is a brief screening tool that measures cognitive function across multiple domains—memory, attention, language, and executive function—to help doctors identify potential cognitive impairment. Scoring works on a straightforward 30-point scale, with most results falling between 0 and 30; a score of 26 or above is generally considered normal cognition, while a score below 26 may suggest mild cognitive impairment or dementia depending on the person’s age and education level. For example, a 68-year-old man who forgets where he parked his car takes the MoCA and scores 22, prompting his doctor to follow up with additional cognitive testing and imaging because his score falls in the range that warrants closer evaluation.
The MoCA was developed in 1996 by Dr. Ziad Nasreddine at a Montreal memory clinic precisely because existing tests like the Mini-Cog and Montreal Test were missing early signs of cognitive decline, especially in highly educated patients who could still perform reasonably on simpler screening tools. The test takes 10 to 15 minutes to administer, making it practical for busy clinical settings. What matters most to understand is that the MoCA is a screening tool, not a diagnostic test—a low score suggests cognitive problems deserve investigation, but it does not by itself confirm dementia or any specific disease.
Table of Contents
- How Is the MoCA Test Scored, and What Do Different Ranges Mean?
- Why the MoCA Catches Subtle Changes That Other Tests Miss
- How the MoCA Compares to Other Cognitive Screening Tests
- Preparing for and Taking the MoCA: What to Expect
- When MoCA Results Are Misleading: Limitations and False Positives
- The MoCA in Diagnosing Mild Cognitive Impairment
- Using MoCA Results to Guide Medical Management and Care Planning
- Frequently Asked Questions
How Is the MoCA Test Scored, and What Do Different Ranges Mean?
The moca divides into specific cognitive domains, each with a point value assigned to short tasks. The test includes a 3D shape copy (1 point), naming of animal images (3 points), attention tasks like tapping at a specific sound (1 point), repetition of complex sentences (2 points), verbal fluency—naming words that start with a specific letter in 60 seconds (1 point), abstraction of concepts (2 points), delayed recall of the five words introduced earlier (5 points), orientation to date and place (6 points), and a visual recognition task where patients identify which of eight cubes they saw before (1 point). Adding these up creates the 30-point total. The scoring interpretation depends on the test-taker’s age and education.
A score of 26–30 is considered normal. A score of 18–25 typically suggests mild cognitive impairment. A score below 18 raises concern for more moderate or severe cognitive impairment. However, education matters significantly: a 72-year-old person with a high school diploma who scores 24 may be at greater risk than an 85-year-old with a college degree who scores the same, because education influences baseline cognitive performance. Some clinicians apply a cut score of 25 or below for those over age 80 or with less than 12 years of education, and a cut score of 26 for younger, more educated individuals.
Why the MoCA Catches Subtle Changes That Other Tests Miss
The MoCA includes more demanding executive function tasks than shorter screening tests, which is why it often identifies mild cognitive impairment that simpler tests overlook. The Mini-Cog, for instance, relies mainly on drawing a clock and recalling three words—both important, but not a comprehensive cognitive picture. Someone with early decline in planning, problem-solving, or language might score normally on the Mini-Cog but show deficits in the MoCA’s executive function and verbal fluency sections.
A key limitation of the MoCA is that it performs inconsistently across different languages and populations. In non-English-speaking countries or among people for whom English is a second language, translated versions of the test sometimes show different accuracy compared to the original English version. Additionally, the MoCA can be influenced by education, language ability, and cultural factors independent of actual cognitive decline; a person who has always struggled with timed verbal fluency tasks might score lower even without disease. Sensory problems—hearing loss, poor vision, or tremor that prevents writing—can also artificially lower scores without indicating dementia.
How the MoCA Compares to Other Cognitive Screening Tests
The MoCA is more sensitive to mild cognitive impairment than the Montreal Test or Montreal Mini, but it is more demanding and takes longer than very brief screens. The MMSE (Mini-Mental State Examination), a standard screen for decades, uses only 11 questions and takes 5–10 minutes but misses early cognitive decline in highly educated people or those with only mild impairment. The MoCA was developed partly in response to this limitation. At the other extreme, comprehensive neuropsychological testing involves a psychologist spending 4–8 hours administering dozens of tests in person or online, measuring highly specific cognitive domains with precision; the MoCA is far quicker but far less detailed.
In clinical practice, the MoCA often serves as a second-line screen. A person might first take the Montreal Test or Mini-Cog in a primary care office, and if that is abnormal, the primary care doctor might then administer the MoCA to get a more detailed picture before referring to a neurologist or memory specialist. Some memory clinics skip other screens and go straight to the MoCA because the extra detail is worth the 10-minute time investment. The tradeoff is that a normal MoCA does not entirely rule out cognitive disease—someone with very early Alzheimer’s pathology might score 26 or above, and only when they return for testing in a year or two does decline become apparent.
Preparing for and Taking the MoCA: What to Expect
Before taking the MoCA, a patient should be alert and not in severe pain, acute illness, or intoxication, as these conditions can artificially lower scores. It is reasonable to take the test in the morning when alertness is highest. No specific study or preparation is expected or possible—the MoCA is designed to measure how someone thinks on a typical day, not after cramming. The test administrator should ensure the person can see and hear clearly; if someone wears glasses or hearing aids, these should be in place during testing.
During the test, a patient sits with the administrator, usually in a quiet room, and is given a printed sheet with some tasks and a blank sheet for drawing and writing. The administrator reads prompts and times certain sections. A person should answer honestly and give their best effort, but should also let the administrator know if they do not understand a question or cannot hear it. The test is not a memory test alone—someone might perform poorly on the word recall section but normally on other areas, and that uneven profile itself contains useful information about which cognitive systems are affected.
When MoCA Results Are Misleading: Limitations and False Positives
The MoCA can produce false positives—low scores in people without dementia—especially in those with depression, anxiety, sleep deprivation, or delirium from infection or medication. A 76-year-old woman hospitalized with a urinary tract infection might score 20 on the MoCA due to the acute confusion from infection, but her actual baseline cognitive function may be much higher once the infection is treated. This is why a single MoCA score should never be used to diagnose dementia on its own.
Additionally, the MoCA has not been validated equally well in all racial and ethnic groups; there is some evidence that African American and Hispanic populations score lower on average, partly due to factors related to education opportunity and test language, not actual cognitive difference. A doctor using the MoCA should be aware of these population differences and avoid over-interpreting a low score without considering the person’s background and education. Stroke, Parkinson’s disease, depression, and attention deficit disorder can all produce lower MoCA scores that do not reflect the type of cognitive change seen in Alzheimer’s or other dementias.
The MoCA in Diagnosing Mild Cognitive Impairment
Mild cognitive impairment, or MCI, is a stage where cognitive changes are measurable and noticeable to the person or family but do not yet interfere significantly with daily function. A score of 18–25 on the MoCA often flags people who fit this profile, especially if the person also reports forgetting names, appointments, or having trouble with complex mental tasks. However, not everyone with an MoCA score of 18–25 has MCI—some are in the process of normal aging, and some are acutely ill or depressed—so additional evaluation is necessary.
Following someone’s MoCA score over time is more valuable than a single score. If the same person scores 28, then 26, then 24 over the course of two years, that downward trend suggests real cognitive decline even if the individual score of 24 might be borderline. Conversely, someone who scores 20 on one test and 21 on the next test six months later may simply have variation in performance or may benefit from treating treatable conditions like sleep apnea or high blood pressure, which can then halt the decline.
Using MoCA Results to Guide Medical Management and Care Planning
A low MoCA score typically prompts further workup: blood tests to check for B12 deficiency, thyroid disorder, or other metabolic problems; imaging such as MRI to look for stroke, brain tumor, or other structural problems; and often referral to a neurologist or memory specialist for a formal diagnosis. A person with a score of 22 and a six-month history of increasing forgetfulness might undergo these tests, discover Alzheimer-type pathology on MRI, and then begin medication such as a cholinesterase inhibitor or newer anti-amyloid therapy. The MoCA score alone does not determine treatment, but it does determine whether that investigation happens.
Doctors also use the MoCA to monitor response to treatment or to document decline over time in medical records. If someone starts a new dementia medication and is retested three months later, an improvement in MoCA score—or stabilization when decline was expected—suggests the medication is helping. A person’s MoCA score is also relevant to driving safety, financial capacity, and whether they need a caregiver or legal power of attorney; a score significantly below 20, especially with deficits in attention or executive function, often leads a doctor to have explicit conversations about these real-world abilities.
- —
Frequently Asked Questions
Can I take the MoCA test at home or online?
The MoCA is designed to be administered in person by a trained healthcare provider who can observe behavior, ensure clarity, and time specific tasks accurately. Some telemedicine versions exist, but accuracy may be reduced, especially if vision or hearing is poor or if the test-taker cannot follow onscreen instructions clearly.
What if I score in the abnormal range—does that mean I have dementia?
No. An abnormal MoCA score means your cognitive function in one or more areas is lower than expected for your age and education level, and you need further evaluation. Many conditions—depression, delirium, medication side effects, or even a bad night’s sleep—can lower your score without indicating dementia.
How often should the MoCA be repeated?
There is no universal schedule. If you have been diagnosed with mild cognitive impairment or dementia, your doctor might repeat it every 6–12 months to track changes. If you are screening for risk factors or have normal results, repetition depends on your symptoms and risk profile. Annual screening is common for people concerned about memory decline.
Is the MoCA the same in every country?
The MoCA has been translated into many languages, and the structure is the same, but there are some differences in how items are named or which specific language-based tasks are used. A Spanish version may have different word fluency prompts than an English version, for example. Results are generally comparable, but regional norms may apply.
Does a high MoCA score mean I cannot develop dementia?
No. A normal MoCA score today does not guarantee future cognitive health. Some people with normal MoCA scores have early Alzheimer’s pathology in their brain that may not show up as cognitive decline for several more years. The MoCA measures current cognitive function, not future risk or brain pathology.
Can I prepare or study for the MoCA?
Not in a meaningful way. The MoCA is designed to measure how your mind works on a typical day. Cramming or memorizing facts will not improve your underlying cognitive ability. The best preparation is to be well-rested, alert, and ready to do your best effort on the day of the test. —
